感染症の予防・診断・治療法を創出するためには、病原微生物の特性解明、生体防御機構の理解、新たな創薬モダリティの開発が不可欠です。当部門では、感染症の根本的な克服を目指し、基礎研究を推進しています。特に、病原性微生物の特性や、それに対する生体防御応答メカニズムの解明に重点を置くとともに、新たな知見に基づく治療法の開発に取り組んでいます。微生物学、生体防御学、臨床生命工学などの専門家が連携し、分野横断的な基礎研究を総合的に展開します。

Characterizing pathogenic microorganisms, understanding host defense mechanisms, and developing novel therapeutic modalities are essential for creating methods for prevention, diagnosis, and treatment of infectious diseases. This division is dedicated to basic research aimed at overcoming infectious diseases. Special focus is placed on elucidating the characteristics of pathogenic microorganisms and host defense mechanisms against them, as well as developing innovative treatment strategies based on new scientific insights. Experts in microbiology, host defense, and biomedical engineering will collaborate to drive interdisciplinary research.

感染症対策の質を高め、臨床現場での対応力を強化するためには、医療従事者やこれから医療従事者になる人々に対して、最新の感染症対策や検査技術に関する教育を行うことが重要です。当部門では、将来の感染症対策リーダーや検査技術開発者を育成することを目的に、現場の実情に即した様々な教育コンテンツを準備し、幅広い人材育成を行います。また、今後求められる医療ニーズを的確に把握し、変化に柔軟かつ迅速に対応できる医療人材育成教育を整えます。

Education of current and future medical professionals on the latest practices and laboratory techniques for infectious diseases is essential for enhancing infectious disease control measures and improving responsiveness in clinical environment. This division develops a wide range of educational programs tailored to clinical needs, with the goal of cultivating the next generation of leaders in infectious disease control and researchers developing new testing technology. In addition, the division will accurately grasp the medical needs required in the future and provide medical human resource education that can respond flexibly and quickly to changes.

感染症パンデミックのような事態においても、社会・経済活動を持続的に維持・発展させるには、分野や組織の枠を超えた研究者の連携が不可欠です。当部門では、リスク評価や政策立案に必要な情報の収集・分析を通じて、エビデンスを踏まえた政策立案（Evidence-Informed Policy Making: EIPM）や効果的な情報発信を推進します。また、感染症に限らず、予測困難でありながら健康への影響が大きい問題（Unexpected Health Issues: UHI）に、文理融合のアプローチで取り組み、社会のレジリエンス向上に貢献します。

Interdisciplinary and cross-organizational collaboration is essential for sustaining and developing social and economic activities in the event of infectious disease pandemics. This division promotes Evidence-Informed Policy Making (EIPM) and effective information dissemination by collecting and analyzing data essential for risk assessment and policy development. In addition, the division addresses Unexpected Health Issues (UHI), which are not limited to infectious diseases, but are difficult to predict and may have a major impact on health, by integrating approaches from both the humanities and sciences. It thereby contributes to strengthening the resilience of society against future health crises.